Source comparison
MK-677 Popular in Research: Full Comparison
Before detailing scenario-based applications, understanding how MK-677 compares to alternative interventions clarifies why researchers select it for specific study designs. MK-677 (Ibutamoren) Ghrelin receptor agonist; stimulates endogenous GH pulsatile releas
This comparison does not assign a generated winner or score.
- Before detailing scenario-based applications, understanding how MK-677 compares to alternative interventions clarifies why researchers select it for specific study designs.
- MK-677 (Ibutamoren)
- Ghrelin receptor agonist; stimulates endogenous GH pulsatile release
- Physiological pulsatile (preserved ultradian rhythm)
- None. Works upstream of negative feedback loop
- Oral, once daily
- 8 weeks to 24 months
- Ideal for long-term metabolic and body composition research requiring sustained GH/IGF-1 elevation without endocrine suppression
- Exogenous rhGH Injection
- Direct GH receptor binding in peripheral tissues
- Continuous elevation (non-physiological)
- High. Suppresses endogenous production within 2–4 weeks
- Subcutaneous injection, daily or twice-daily
- 4–12 weeks maximum before tachyphylaxis
- Useful for short-term pharmacokinetic studies but unsuitable for protocols requiring natural axis preservation
- GHRP-2
- GHRH and ghrelin receptor agonist; stimulates pituitary GH release
- Pulsatile, amplitude depends on dose timing
- Minimal when dosed appropriately
- Subcutaneous injection, 2–3× daily
- 4–16 weeks
- Effective for research requiring precise control over GH pulse timing but requires frequent dosing
- CJC-1295 (DAC)
- GHRH analogue with extended half-life
- Sustained elevation with blunted peaks
- Low to moderate with chronic use
- Subcutaneous injection, once or twice weekly
- 8–20 weeks
- Bridges the gap between pulsatile and continuous patterns; useful when stable GH elevation matters more than peak amplitude
- Dietary Intervention Alone
- Indirect via insulin modulation, fasting-induced GH spikes
- Highly variable, dependent on meal timing and macronutrient composition
- None
- N/A
- Ongoing
- Produces inconsistent GH response unsuitable as sole intervention in controlled research